Effective anesthetic management with remimazolam and ketamine without muscle relaxants for parotidectomy in a patient with myotonic dystrophy: A case report

Patients with myotonic dystrophy (DM) are highly sensitive to anesthetics, muscle relaxants, and opioids, necessitating appropriate anesthetic management. Recently, remimazolam, an ultra-short-acting benzodiazepine, has been approved for use as a general anesthetic in Japan, and patients with DM hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Yoshiaki, Habu, Miki (Iwasaki), Toba, Yoshie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410637/
https://www.ncbi.nlm.nih.gov/pubmed/36042643
http://dx.doi.org/10.1097/MD.0000000000030415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410637/
https://www.ncbi.nlm.nih.gov/pubmed/36042643
http://dx.doi.org/10.1097/MD.0000000000030415

Ejemplares similares